Prospects for immunotherapy of MHC class I-deficient tumours.
Bubeník
J
J
D000818:Animals; D002986:Clinical Trials as Topic; D015536:Down-Regulation; D005434:Flow Cytometry; D005805:Genes, MHC Class I / Q000235:genetics; D015395:Histocompatibility Antigens Class I / Q000096:biosynthesis*; D006801:Humans; D007167:Immunotherapy / Q000379:methods*; D051379:Mice; D009369:Neoplasms / Q000276:immunology* / Q000628:therapy*
D015395:Histocompatibility Antigens Class I